PMID: 9652735Jul 4, 1998Paper

Fournier's gangrene as first presentation of promyelocytic leukemia

Leukemia Research
H J FaberS Daenen

Abstract

A 50-year-old male is described who presented with Fournier's gangrene as what is probably the first manifestation of a newly diagnosed acute myelogenous leukemia (AML), promyelocytic type or variant type M3 according to the FAB classification. Despite aggressive fluid resuscitation, tuned infusion of vasoactive drugs, appropriate antibiotics and extensive surgical debridement, the patient died within 24 h as a result of irreversible septic shock.

References

Jul 1, 1977·American Journal of Surgery·A GiulianoF W Blaisdell
Nov 1, 1990·Journal of Clinical Pathology·B Bain, D Catovsky
Jan 1, 1983·Archives of Surgery·R C Lamb, G L Juler
Jul 1, 1995·The Journal of Urology·E LaorH I Winter
Jun 1, 1996·Urology·E BenizriJ Toubol
Jul 1, 1958·The Journal of Infectious Diseases·S E MERGENHAGENH W SCHERP
Aug 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John Alfred Carr

❮ Previous
Next ❯

Citations

Nov 27, 2007·JAAPA : Official Journal of the American Academy of Physician Assistants·Draion M BurchVincent W Vanek
Aug 7, 2012·Journal of the American College of Surgeons·Antonis A KousoulisSotirios Tsiodras
Sep 30, 2003·Medical and Pediatric Oncology·Chetna BakshiSuresh Advani
Jan 21, 2006·Pediatric Blood & Cancer·Elpis MantadakisGeorge Samonis
Dec 21, 2018·BMJ Case Reports·Vanessa Fiorini FurtadoJohn Mark Sloan
Sep 27, 2000·Diseases of the Colon and Rectum·R J YaghanI Bani-Hani
Oct 5, 2021·ANZ Journal of Surgery·Sharon Chih Lin LeeKrinal Mori

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.